Reference : The use of acarbose in the prevention and treatment of hypoglycaemia.
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/14005
The use of acarbose in the prevention and treatment of hypoglycaemia.
English
Lefebvre, Pierre [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
1994
European Journal of Clinical Investigation
Blackwell Publishing
24 Suppl 3
40-4
Yes (verified by ORBi)
0014-2972
1365-2362
Oxford
United Kingdom
[en] Acarbose ; Blood Glucose/metabolism ; Diabetes Mellitus, Type 1/blood/drug therapy ; Diabetes Mellitus, Type 2/blood/drug therapy ; Eating ; Humans ; Hypoglycemia/drug therapy/prevention & control ; Hypoglycemic Agents/therapeutic use ; Sulfonylurea Compounds/therapeutic use ; Trisaccharides/pharmacology/therapeutic use ; alpha-Glucosidases/antagonists & inhibitors
[en] This paper reviews the use of acarbose in the prevention and treatment of hypoglycaemia. In diet- or sulfonylurea-treated patients, acarbose may reduce the incidence of late postprandial hypoglycaemia. In insulin-treated patients, acarbose treatment usually requires reduction of the insulin dose; one study has shown that 100 mg acarbose at night significantly reduces the incidence of mid-evening and nocturnal hypoglycaemia. Several studies have suggested acarbose to be a useful adjunct to the management of reactive hypoglycaemia in the non-diabetic patients. Long-term prospective studies are still needed to document this last indication of acarbose or other alpha-glycosidase inhibitors.
http://hdl.handle.net/2268/14005

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.